Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-36
Closed -$2.72K 1251
2026
Q1
$2.72K Sell
36
-295
-89% -$22.2K ﹤0.01% 902
2025
Q4
$24.7K Sell
331
-1,053
-76% -$76.9K ﹤0.01% 764
2025
Q3
$93.4K Buy
1,384
+1,234
+823% +$81.9K 0.02% 407
2025
Q2
$9.77K Buy
+150
New +$8.99K ﹤0.01% 891
2023
Q3
Sell
-322
Closed -$26K 771
2023
Q2
$26K Sell
322
-162
-33% -$13.2K ﹤0.01% 563
2023
Q1
$39K Buy
484
+231
+91% +$18.6K ﹤0.01% 478
2022
Q4
$19K Sell
253
-109
-30% -$7.76K ﹤0.01% 915
2022
Q3
$23K Sell
362
-158
-30% -$10.9K ﹤0.01% 702
2022
Q2
$36K Buy
520
+418
+410% +$31K ﹤0.01% 634
2022
Q1
$8K Buy
+102
New +$7.33K ﹤0.01% 879

Other funds holding HOLX

Summit Securities Group's HOLX Position: Q2 2026 in Review

Summit Securities Group sold out of Hologic (HOLX) in Q2 2026, closing a stake of 36 shares — an estimated $2.72K sold.

Summit Securities Group first reported a position in HOLX in Q1 2022 and held it in 10 quarters. The position peaked at $93.4K in Q3 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Summit Securities Group reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Summit Securities Group sold 36 Hologic shares in Q2 2026, an estimated $2.72K.
  • Summit Securities Group first reported a position in Hologic in Q1 2022 and held it in 10 quarters.
  • Summit Securities Group's Hologic position peaked at $93.4K in Q3 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.